Patents by Inventor Nam Hoang Dang

Nam Hoang Dang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anti-CD26 monoclonal antibodies as therapy for diseases associated with cells expressing CD26
    Patent number: 7658923
    Abstract: Therapeutic methods comprising administering anti-CD26 antibodies for the prevention and treatment of cancers and immune diseases associated with expressing CD26 are provided. The invention describes various types of anti-CD26 antibodies and modes of administration.
    Type: Grant
    Filed: February 16, 2007
    Date of Patent: February 9, 2010
    Assignees: Board of Regents, The University of Texas System, Dana-Farber Cancer Institute
    Inventors: Nam Hoang Dang, Chikao Morimoto, Stuart Schlossman
  • Methods and Systems for Detecting Antiangiogenesis
    Publication number: 20080318241
    Abstract: The present invention provides methods and systems for the detection of tumor vessel response to antiangiogenic therapies. The present invention also provides compositions and methods for therapeutic and research applications. In particular, the present invention provides systems and methods that employ CD26, HIF-1, and HIF-1 pathway components as biomarkers for monitoring antiangiogenic therapies and as therapeutic targets.
    Type: Application
    Filed: June 17, 2008
    Publication date: December 25, 2008
    Applicants: THE REGENTS OF THE UNIVERSITY OF MICHIGAN, NEVADA CANCER INSTITUTE
    Inventors: Long Hoang Dang, Ngoc-Duyen Thi Dang, Nam Hoang Dang
  • Anti-CD26 monoclonal antibodies as therapy for diseases associated with cells expressing CD26.
    Patent number: 7198788
    Abstract: Therapeutic methods comprising administering anti-CD26 antibodies for the prevention and treatment of cancers and immune diseases associated with expressing CD26 are provided. The invention describes various types of anti-CD26 antibodies and modes of administration.
    Type: Grant
    Filed: May 10, 2002
    Date of Patent: April 3, 2007
    Assignees: Board of Regents, The University of Texas System, Dana-Farber Cancer Institute
    Inventors: Nam Hoang Dang, Chikao Morimoto, Stuart Schlossman
  • Anti-CD26 monoclonal antibodies as therapy for diseases associated with cells expressing CD26
    Publication number: 20030031665
    Abstract: Therapeutic methods comprising administering anti-CD26 antibodies for the prevention and treatment of cancers and immune diseases associated with expressing CD26 are provided. The invention describes various types of anti-CD26 antibodies and modes of administration.
    Type: Application
    Filed: May 10, 2002
    Publication date: February 13, 2003
    Inventors: Nam Hoang Dang, Chikao Morimoto, Stuart Schlossman